The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Activation by zoledoronic acid and IL-18 of γδ T cells from early-stage breast cancer patients in the context of helper NK cells.
Tomoharu Sugie
No relevant relationships to disclose
Kaoru Murata-Hirai
No relevant relationships to disclose
Masashi Iwasaki
No relevant relationships to disclose
Craig T Morita
No relevant relationships to disclose
Wen Li
No relevant relationships to disclose
Haruki Okamura
No relevant relationships to disclose
Nagahiro Minato
No relevant relationships to disclose
Masakazu Toi
No relevant relationships to disclose
Yoshimasa Tanaka
No relevant relationships to disclose